Asymchem Laboratories (Tianjin) Company Description
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally.
The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients.
It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions.
In addition, the company is involved in development and drug product manufacturing; provision of pharmaceutical analysis and testing services; medical research and development; manufacturing, sale, and development of medicine raw materials and relevant products; sale of drug products; pharmaceuticals and chemical manufacturing; wholesaling and retailing of drugs; sale, import and export trade; information technology; technology development; and research and experimental development activities.
The company was founded in 1998 and is headquartered in Tianjin, China.
Country | China |
Founded | 1998 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 9,788 |
Contact Details
Address: No. 6 Dongting 3rd Street Tianjin, 300457 China | |
Website | asymchem.com.cn |
Stock Details
Ticker Symbol | 6821 |
Exchange | Hong Kong Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100004Z06 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Rui Yang | Co-Chief Executive Officer and Executive Director |
Dr. Hao Hong Ph.D. | Founder, Chairman and Chief Executive Officer |
Da Zhang | Chief Financial Officer, Chief Operating Officer, Senior Vice President and Executive Director |
Dr. Liang Hong | Senior Vice President of Process Development and Application and Executive Director |
Elut Hsu | President and GM |
Dr. Xinhui Hu Ph.D. | Chief Technology Officer and CBO |
Dr. James Randolph Gage Ph.D. | Chief Scientific Officer |
Jiang Yingwei | Senior Vice President of Human Resources |
Chaoyong Chen | Senior Vice President of Resource and Development |
Dr. Pingzhong Huang Ph.D. | Senior Vice President of Process Development |